Blog

Strategic Growth: Portal Vein Boost for Liver Resection in Cholangiocarcinoma

When facing borderline resectable intrahepatic cholangiocarcinoma (ICC), inducing hypertrophy pre-resection is a game-changer. In this single-center study, researchers found that portal vein embolization (PVE) prepped the battleground without raising perioperative issues. Overall survival (OS) matched non-PVE cases, but additional risks (multifocal tumors, lymph node involvement) threw a curveball, slashing OS notably. The takeaway? PVE proves a surgical ally for borderline ICC, but watch out for extra foes that might dim the long-term victory glow.

Journal Article by Nevermann N, Bode J (…) Schöning W et 8 al. in Eur J Surg Oncol

© 2023 Published by Elsevier Ltd.

read the whole article in Eur J Surg Oncol

open it in PubMed

A Deep Dive into Anti-Obesity Medications

The battle against obesity is no one-size-fits-all, and this study delves into the arsenal—lifestyle tweaks, anti-obesity meds (AOMs), gadgets, and surgery. Researchers stress the need for a personalized approach, factoring in patient quirks, goals, and health hiccups. In this trial-and-error game, no crystal ball predicts the perfect AOM match. The takeaway? Prescribe sequentially, maybe mix and match, to hit that sweet spot in the fight against the bulge.

Review by Schmitz SH and Aronne LJ in Gastroenterol Clin North Am

Copyright © 2023 Elsevier Inc. All rights reserved.

read the whole article in Gastroenterol Clin North Am

open it in PubMed

Lighting the Way: Fluorescent Tech Nails Esophageal Surgery

Researchers lit up esophageal cancer surgery with near-infrared indocyanine green, exposing the elusive thoracic duct (TD) in 94% of cases. Injecting ICG into inguinal nodes during minimal access esophagectomy, the team showcased real-time TD imaging. The glow guided ligation in 16 cases, minimizing chyle leaks and sidestepping adverse reactions. This illuminating approach, sustaining fluorescence throughout, promises safer surgery, valuable anatomical insights, and a chyle leak-free 30-day recovery for patients.

Journal Article by Thammineedi SR, Patnaik SC (…) Nusrath S et 3 al. in Langenbecks Arch Surg

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

read the whole article in Langenbecks Arch Surg

open it in PubMed

Revolutionizing Support for Surgeon-Scientists: A Blueprint for Sustainable Science

Surgical leaders unite to transform support for surgeon-scientists, facing challenges of institutional neglect and time constraints. Task force recommendations include cultivating a growth mindset in surgeons, emphasizing mentorship with structured accountability, ensuring financial sustainability through diversified funding, and enhancing structural and strategic support. Building a supportive community culture and reshaping institutional and funding agency expectations are crucial. Authentic commitment from stakeholders is vital for harnessing the unique contributions of surgeon-scientists.

Journal Article by Ladner DP, Goldstein AM (…) Hwang ES et 22 al. in Ann Surg

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

Harmony in Hepatic Recovery: Gata3 and Ramp2 Balance Key to Vascular Reconstitution

Unveiling liver regeneration intricacies, this study decodes Gata3 and Ramp2’s role in hepatic-vascular revival post-surgery. These hepatocyte conductors fuel liver sinusoidal endothelial cell proliferation. Pedf and Vegfa, playing contrasting roles in endothelial migration, spice up the dance. Gata3 inhibitors emerge as potential superheroes against post-hepatectomy liver failure. Serum Pedf/Vegfa Index (SPVI) steps in as a savvy predictor. It’s a symphony of hepatocyte moves, unlocking avenues for post-surgery liver recovery and potential treatment strategies.

Journal Article by Bibo W, Hao S (…) Hongyang W et 13 al. in J Hepatol

Copyright © 2023. Published by Elsevier B.V.

read the whole article in J Hepatol

open it in PubMed

Unsupervised Training Proves Effective for Esophago-Gastric Endoscopic Submucosal Dissection

Experienced endoscopists seeking competence in endoscopic submucosal dissection (ESD) faced a challenging learning curve. This study introduced an unsupervised training model. Endoscopists initially observed 30 ESD cases and performed 15 unsupervised ex-vivo ESDs. Afterward, they tackled five human distal gastric ESDs and 55 unselected esophago-gastric cases. Results were promising, with a 93.0% en-bloc resection rate, 80.7% R0 resection rate, and an average operative time of 14.0 minutes per centimeter. Unsupervised training appears to successfully guide experienced endoscopists toward ESD competence.

Journal Article by Hadjinicolaou AV, Pappas A (…) di Pietro M et 3 al. in Gastrointest Endosc

Copyright © 2023 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

read the whole article in Gastrointest Endosc

open it in PubMed

Optimal Timing for Pancreatic Cancer Adjuvant Therapy: A Survival Analysis

Delving into the ideal moment for post-pancreatic adenocarcinoma surgery chemotherapy, a simulated trial tracked 1491 patients. Noteworthy findings revealed a median survival of 29.9 months for late initiators (>4-8 weeks) versus 30.4 months for early starters (0-4 weeks). Encouragingly, delaying treatment up to 8 weeks post-surgery showed comparable safety, offering a nuanced approach that respects recovery timelines and enhances adjuvant therapy accessibility.

Journal Article by Kirkegård J, Ladekarl M, Lund A and Mortensen F in Ann Surg Oncol

© 2023. The Author(s).

read the whole article in Ann Surg Oncol

open it in PubMed

Laparoscopic Showdown: Transperitoneal Triumphs in Tackling Retroperitoneal Tumors

Researchers delved into the battle of surgical approaches for benign retroperitoneal tumors (BRTs). Analyzing data from 43 patients, the laparoscopic transperitoneal approach emerged as the superhero, boasting lower conversion rates and comparable outcomes to its retroperitoneal counterpart. With enhanced visual perspectives and bleeding control, the transperitoneal technique flexed its anatomical advantages, proving especially potent against larger tumors near crucial blood vessels. This study champions the laparoscopic transperitoneal approach as the go-to for tackling BRTs with finesse and efficacy.

Journal Article by Hou Z, Xie Q (…) Huang J et 4 al. in Surg Endosc

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Surg Endosc

open it in PubMed

Crohn’s Surgery: Mesenteric Targeting Strategies Examined

In a daring move, researchers explored the short-term aftermath of groundbreaking mesenteric-targeted techniques in Crohn’s disease surgery. Among 186 patients undergoing innovative approaches like Kono-S anastomosis and extended mesenteric excision, results were surprisingly positive. Despite a slightly longer operation in the mesenteric excision and exclusion group, all factions exhibited comparable postoperative stays, readmission rates, and complication levels. This study signals that reshaping Crohn’s surgery with mesenteric precision is not just a theory—it’s a safe and feasible reality.

Journal Article by Holubar SD, Lipman J (…) Hull T et 10 al. in Am J Surg

Copyright © 2023. Published by Elsevier Inc.

read the whole article in Am J Surg

open it in PubMed

Cracking the Code: Gastrojejunal Anastomosis Holds Clues to Weight Regain in Gastric Bypass Graduates

Researchers delved into the post-gastric bypass world, unraveling the mystery of weight regain (WR). Examining 34 Roux-en-Y gastric bypass alumni, they discovered a correlation between the gastojejunal anastomosis (GJA) diameter and WR. However, excluding outliers with GJA over 30 mm nullified the link. The study highlights the potential of visual GJA estimation and emphasizes that more pliable GJAs (with higher distensibility index) in a subset of patients correlate with reduced WR rates, unlocking insights for clinical management pending larger confirmatory studies.

Journal Article by Razzak FA, Kerbage A (…) Dayyeh BA et 7 al. in Obes Surg

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Obes Surg

open it in PubMed